In vitro anti-HIV-1 activity of the enzymatic extract enriched with laccase produced by the fungi Ganoderma sp. and Lentinus sp.
DOI:
https://doi.org/10.17533/udea.vitae.v23n2a03Keywords:
Human immunodeficiency virus type 1 (HIV-1), Ganoderma, Lentinus, laccase, antiviral activity, natural products.Abstract
Background: Natural compounds are a good source for the development of antiretroviral drugs with low cytotoxicity. The laccase enzyme, produced by fungi of the genera Ganoderma sp. and Lentinus sp., inhibits the reverse transcriptase (RT) of the human immunodeficiency virus 1 (HIV-1), in cell-free models in vitro. Aims: In this study we evaluated the anti-HIV-1 activity of the enzymatic crude (EC) enriched with laccase, produced by two native species of fungi of the same genera in an in vitro cell culture model. Methods: The inhibition of viral replication was performed using the U373-MAGI cell line infected with recombinant viruses in the presence/absence of the EC and 48 hpi, the percentage of infected cells was evaluated by flow cytometry for GFP and ELISA for p24. The inhibition of the RT was determined by quantification of early and late products of reverse transcription using quantitative PCR. Results: The ECs from Ganoderma sp. and Lentinus sp. inhibited the replication of HIV-1 between 80 and 90% and decreased the production of early and late transcripts between 55,5%-91,3% and 82,1%-93,6% respectively. The EC from Lentinus sp. had the best selectivity index (SI: 4.77). Conclusions: These results suggest the potential anti-HIV-1 of the EC for the exploration of an alternative therapy against HIV-1 infection.
Downloads
References
Kolber MA, Saenz MO, Tanner TJ, Arheart KL, Pahwa S, Liu H. Intensification of a suppressive HAART regimen increases CD4 counts and decreases CD8+ T-cell activation. Clin Immunol. 2008;126(3):315-21.
Wang HX, Ng TB. Purification of a novel low-molecular-mass laccase with HIV-1 reverse transcriptase inhibitory activity from the mushroom Tricholoma giganteum. Biochem Biophys Res Commun. 2004;315(2):450-4.
Wang HX, Ng TB. A new laccase from dried fruiting bodies of the monkey head mushroom Hericium erinaceum. Biochem Biophys Res Commun. 2004;322(1):17-21.
Wang J, Wang HX, Ng TB. A peptide with HIV-1 reverse transcriptase inhibitory activity from the medicinal mushroom Russula paludosa. Peptides. 2007;28(3):560-5.
Wang H, Ng T. Eryngin, a novel antifungal peptide from fruiting bodies of the edible mushroom Pleurotus eryngii. Peptides. 2004;25(1):1-5.
Wang HX, Ng TB. A laccase from the medicinal mushroom Ganoderma lucidum. Appl Microbiol Biotechnol. 2006;72(3):508-13.
Sun J, Wang H, Ng TB. Isolation of a laccase with HIV-1 reverse transcriptase inhibitory activity from fresh fruiting bodies of the Lentinus edodes (Shiitake mushroom). Indian J Biochem Biophys. 2011;48(2):88-94.
Eo SK, Kim YS, Lee CK, Han SS. Possible mode of antiviral activity of acidic protein bound polysaccharide isolated from Ganoderma lucidum on herpes simplex viruses. J Ethnopharmacol. 2000;72(3):475-81.
Lee K-H, Morris-Natschke SL, Yang X, Huang R, Zhou T, Wu S-F, et al. Recent progress of research on medicinal mushrooms, foods, and other herbal products used in traditional Chinese medicine. J Tradit Complement Med. 2012;2(2):84-95.
Gao Y, Tang W, Gao H, Chan E, Lan J, Li X, et al. Antimicrobial Activity of the Medicinal Mushroom Ganoderma. Food Rev Int. 2005;21(2):211-29.
Arboleda C, Mejía AI, Franco-Molano AE, Jiménez GA, Penninckx MJ. Autochthonous white rot fungi from the tropical forest of Colombia for dye decolourisation and ligninolytic enzymes production. Sydowia . 2008;2(60):15.
Xu L, Wang H, Ng T. A laccase with HIV-1 reverse transcriptase inhibitory activity from the broth of mycelial culture of the mushroom Lentinus tigrinus. J Biomed Biotechnol. 2012;2012:536725.
Sun J, Chen QJ, Cao QQ, Wu YY, Xu LJ, Zhu MJ, et al. A laccase with antiproliferative and HIV-I reverse transcriptase inhibitory activities from the mycorrhizal fungus Agaricus placomyces. J Biomed Biotechnol. 2012;2012:736472.
Wong JH, Ng TB, Jiang Y, Liu F, Sze SC, Zhang KY. Purification and characterization of a Laccase withinhibitory activity toward HIV-1 reverse transcriptase and tumor cells from an edible mushroom (Pleurotus cornucopiae). Protein Pept Lett. 2010;17(8):1040-7. n and characterization of a laccase from the edible wild mushroom Tricholoma
Jordan M, Schallhorn A, Wurm FM. Transfecting mammalian cells: Optimization of critical parameters affecting
calcium-phosphate precipitate formation. Nucleic Acids Res. 1996;24(4):596-601.
Vetter ML, D’Aquila RT. Cytoplasmic APOBEC3G restricts incoming Vif-positive human immunodeficiency virus type 1 and increases two-long terminal repeat circle formation in activated T-helper-subtype cells. J Virol. 2009;83(17):8646-54.
Skern R, Frost P, Nilsen F. Relative transcript quantification by quantitative PCR: roughly right or precisely wrong? BMC Mol Biol. 2005;6(1):10.
Thurston CF. The structure and function of fungal laccases. Microbiology. 1994. 19-26 p.
Chattopadhyay D, Sarkar MC, Chatterjee T, Sharma Dey R, Bag P, Chakraborti S, et al. Recent advancements for the evaluation of anti-viral activities of natural products. N Biotechnol. 2009;25(5):347-68.
Notka F, Meier GR, Wagner R. Inhibition of wild-type human immunodeficiency virus and reverse transcriptase inhibitorresistant variants by Phyllanthus amarus. Antiviral Res. 2003;58(2):175-86.
Balzarini ], Kang GJ, Dalal M, Herdewijn P, de Clercq E, Broder S, et al. The anti-HTLVIII (anti-HIV) and cytotoxic activity of 2’,3’-didehydro-2’,3’-dideoxynucleosides: a comparison with their parental 2’,3’-dideoxynucleosides. Mol. Pharmacal. 1987;32:162-167
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Vitae
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright Notice and Open Access Statement
The Journal Vitae works under the Open Access license, and the published manuscripts remain available for the public, both on the Journal's website and in databases, under the Creative Commons license, "Noncommercial Attribution" and "Share alike" systems, adopted in Colombia. Hence, when the authors agree to publish in the Journal Vitae, they will not have the right to economic retributions on publications and reproductions through different diffusion media. The documents are freely available to the internet public, permitting users to read, download, copy, distribute, print, search, or link to the full texts and pass them as data to software. The only constraint on reproduction and distribution, should be to give authors control over the integrity of their work and the right to be appropriately acknowledged and cited.
Authors declare that:
-
They are the intellectual property owners and are responsible for all the information stated in the article.
-
This manuscript has not been submitted or published in other printed or digital media. They accept the responsibility for the judgments, opinions, and points of view expressed in the published article and, therefore, they exonerate Universidad de Antioquia and Journal Vitae from any process.
-
They exempt Universidad de Antioquia and Journal Vitae from settling conflicts or disputes related to the authorship of the referred article.
-
They accept the revision of the original manuscript by suitable personnel, and they bind themselves to perform the corrections appointed or suggested by the assessors.
-
Therefore, they know the editorial process and will not bind the Editorial Board of the Journal to assume any obligations regarding the volume and issue in which the article is published.
-
They transfer the rights of publication, reprinting, and distribution of the article from the moment of its approval, in print and digital format, without the right to economic rewards, and under the licensing conditions considered relevant by Journal Vitae.
-
They fully authorize Universidad de Antioquia and Journal Vitae to submit the published material to the diverse databases and indexing systems where the Journal can be found to comply with the requirements of the regulatory authorities to maintain the national classification of journals.
-
They will assume the article publication costs established for the current issue, and they will make the payment as soon as they are informed about the volume and the issue in which the final version of the article is published.
-
After the article is published, you can share digital or printed copies in a noncommercial manner. You will be able to use the paper in your institution or company for educational or research purposes, including the use in course programs.
Conflict of interest: Authors are responsible for recognizing and disclosing any financial or other benefits that could be perceived to bias their work, acknowledging all financial support and any personal connections with potential sponsors. Examples of such conflicts include receiving research funds or honoraria, serving on advisory boards, stock ownership, or employment and consulting arrangements. Authors without such connections should clearly state that they have no financial support or personal relationships that could be perceived to bias their work. All conflicts of interest should be disclosed on the author's identification page of the manuscript.
